Good morning, everyone, and thank you for joining Kiniksa Pharmaceuticals, Ltd.'s call to discuss our fourth quarter and full ...
Today, I am joined by our Chairman and Chief Executive Officer, Andrew Scott Robinson, and Chief Financial Officer, Mark William Haushill. The market is becoming more competitive and difficult for ...
Baron India Fund® appreciated 0.42% (Institutional Shares) during the final quarter of 2025, while MSCI AC Asia ex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results